Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Treatment of Patients With Stable Ischemic Heart Disease--Reply.

JAMA.
Polonsky TS, Blankstein R.
| May 3, 2016
2.

Association Between Availability of a Price Transparency Tool and Outpatient Spending.

JAMA.
Desai S, Hatfield LA, Hicks AL, Chernew ME, Mehrotra A.
| May 3, 2016
3.

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.

JAMA.
Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA.
| May 3, 2016
5.

Patient Safety at the Crossroads.

JAMA.
Gandhi TK, Berwick DM, Shojania KG.
| May 3, 2016
6.

Toward an Integrated Federal Health System.

JAMA.
Khullar D, Chokshi DA.
| Apr 28, 2016
7.

Mechanical Thrombectomy and Functional Outcomes After Stroke.

JAMA.
Elgendy IY, Bhatt DL, Bavry AA.
| Apr 26, 2016
8.

Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts.

JAMA.
Rafferty EA, Durand MA, Conant EF, Copit DS, Friedewald SM, Plecha DM, Miller DP.
| Apr 26, 2016
9.

Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women.

JAMA.
Vetter C, Devore EE, Wegrzyn LR, Massa J, Speizer FE, Kawachi I, Rosner B, Stampfer MJ, Schernhammer ES.
| Apr 26, 2016
10.

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation.

JAMA.
Kesselheim AS, Woloshin S, Eddings W, Franklin JM, Ross KM, Schwartz LM.
| Apr 12, 2016
11.

Specialty-Based Global Payment: A New Phase in Payment Reform.

JAMA.
Song Z, Colla CH.
| Apr 25, 2016
12.

Efficacy of the Priority Review Voucher Program.

JAMA.
Sarpatwari A, Kesselheim AS.
| Apr 19, 2016
13.

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.

JAMA.
Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua AM, Patnaik A, Hwu WJ, Weber JS, Gangadhar TC, Hersey P, Dronca R, Joseph RW, Zarour H, Chmielowski B, Lawrence DP, Algazi A, Rizvi NA, Hoffner B, Mateus C, Gergich K, Lindia JA, Giannotti M, Li XN, Ebbinghaus S, Kang SP, Robert C.
| Apr 19, 2016
15.

Screening Mammography and Age Recommendations--Reply.

JAMA.
Keating NL, Pace LE.
| Apr 5, 2016
16.

Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement.

JAMA.
Siu AL, Bibbins-Domingo K, Grossman DC, Davidson KW, Epling JW, García FA, Gillman M, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Harper DM, Phillips WR, Phipps MG, Pignone MP.
| Apr 5, 2016
17.

Lifespan Weighed Down by Diet.

JAMA.
Ludwig DS.
| Apr 4, 2016
18.

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

JAMA.
O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA, Ardissino D.
| Apr 19, 2016
20.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

JAMA.
Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L, Kaplan A.
| Apr 26, 2016